QNCX

NASDAQ · Biotechnology

Quince Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.14

-0.01 (-4.79%)

As of Feb 8, 2:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +28,756.9% upside

Low Target $31.69

Average Target $40.14

High Target $63.06

Current Price $0.14

Current
$0.14

Target
$40.14

$31.69 $40.14 avg $63.06

Scenario Analysis

Bear Case

$31.69

22,682.2%

Low target

Base Case

$40.14

+28,756.9%

Avg target

Bull Case

$63.06

+45,234.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$52.68

-99.7% from high

52-Week Low

$23.29

+-99.4% from low

Target vs 52W High

$40.14

-23.8% vs high

Next Earnings Report

Mar 3, 2026 · After Market Close

15d

until earnings

EPS Est: $-0.23

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%